Bridgewealth Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Sell
1,321
-4
-0.3% -$1.37K 0.09% 82
2026
Q1
$466K Buy
1,325
+6
+0.5% +$2.14K 0.1% 84
2025
Q4
$432K Buy
1,319
+5
+0.4% +$1.59K 0.1% 81
2025
Q3
$371K Sell
1,314
-5
-0.4% -$1.45K 0.09% 84
2025
Q2
$368K Buy
+1,319
New +$374K 0.09% 81
2025
Q1
Sell
-1,598
Closed -$475K 52
2024
Q4
$475K Buy
+1,598
New +$474K 0.13% 62

Other funds holding AMGN

Bridgewealth Advisory Group's AMGN Position: Q2 2026 in Review

Bridgewealth Advisory Group reduced its Amgen (AMGN) stake by 0.3% in Q2 2026, selling an estimated $1.37K and leaving 1,321 shares worth $478K. The position accounts for 0.09% of the portfolio, ranked #82.

Bridgewealth Advisory Group first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bridgewealth Advisory Group held 1,321 shares of Amgen worth $478K as of Q2 2026.
  • Bridgewealth Advisory Group sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.09% of Bridgewealth Advisory Group's portfolio in Q2 2026, its #82 holding.
  • Bridgewealth Advisory Group first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bridgewealth Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.